These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30227748)

  • 41. Optimisation of antirheumatic drug treatment in pregnancy.
    Ostesen M
    Clin Pharmacokinet; 1994 Dec; 27(6):486-503. PubMed ID: 7882637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biologics and cardiovascular risk].
    Tarner IH; Müller-Ladner U; Hamm C
    Z Rheumatol; 2010 Oct; 69(8):702-6, 708-11. PubMed ID: 20862482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disease-modifying anti-rheumatic drug use in pregnant women with rheumatic diseases: a systematic review of the risk of congenital malformations.
    Baldwin C; Avina-Zubieta A; Rai SK; Carruthers E; De Vera MA
    Clin Exp Rheumatol; 2016; 34(2):172-83. PubMed ID: 26940667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Rheumatic diseases need more attention in case of the desire to have children and during pregnancy].
    de Man YA; Dolhain RJ; Steegers EA; Hazes JM
    Ned Tijdschr Geneeskd; 2011; 155(13):A2622. PubMed ID: 21447200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infection risk and biologics: current update.
    Wallis D
    Curr Opin Rheumatol; 2014 Jul; 26(4):404-9. PubMed ID: 24827752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system.
    Wieringa JW; Driessen GJ; Van Der Woude CJ
    Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):811-818. PubMed ID: 29972674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biologic therapy and pregnancy. A systematic literature review.
    Bogas M; Leandro MJ
    Acta Reumatol Port; 2011; 36(3):219-32. PubMed ID: 22113598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paternal safety of anti-rheumatic medications.
    Bermas BL
    Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():77-84. PubMed ID: 31727565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases.
    Elliott AB; Chakravarty EF
    Womens Health (Lond); 2010 May; 6(3):431-40; quiz 441-2. PubMed ID: 20426608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biologics during pregnancy and breast--feeding].
    Fischer-Betz RE; Schneider M
    Z Rheumatol; 2010 Nov; 69(9):780-7. PubMed ID: 21063826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study.
    Pascart T; Philippe P; Drumez E; Deprez X; Cortet B; Duhamel A; Houvenagel E; Flipo RM
    Int J Rheum Dis; 2016 Nov; 19(11):1093-1102. PubMed ID: 27018857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antirheumatic drugs in pregnancy and lactation.
    Temprano KK; Bandlamudi R; Moore TL
    Semin Arthritis Rheum; 2005 Oct; 35(2):112-21. PubMed ID: 16194696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies.
    Singh JA
    Curr Rheumatol Rep; 2016 Oct; 18(10):61. PubMed ID: 27613285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The new biologics in pregnancy.
    Pupco A
    J Popul Ther Clin Pharmacol; 2014; 21(3):e548-54. PubMed ID: 25527794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drugs in pregnancy. Rheumatological disorders.
    Østensen M
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):953-69. PubMed ID: 11800535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of synthetic and biologic DMARDs during pregnancy.
    Balbi GGM; Domingues V; Balbi GGM; De Jesús GR; Levy RA
    Expert Rev Clin Immunol; 2019 Jan; 15(1):27-39. PubMed ID: 30365902
    [No Abstract]   [Full Text] [Related]  

  • 57. Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.
    Androulakis I; Zavos C; Christopoulos P; Mastorakos G; Gazouli M
    World J Gastroenterol; 2015 Dec; 21(47):13205-11. PubMed ID: 26715803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    McConnell RA; Mahadevan U
    Inflamm Bowel Dis; 2016 Jan; 22(1):213-23. PubMed ID: 26444103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?
    Wendling D; Di Martino V; Herbein G
    J Rheumatol; 2009 Jun; 36(6):1107-8. PubMed ID: 19509089
    [No Abstract]   [Full Text] [Related]  

  • 60. Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
    Tan BE; Lim AL; Kan SL; Lim CH; Tsang EEL; Ch'ng SS; Mohd Noor N; Mohd Jamid N; Teh CL; Joshua Thundyil R; Loh YL; Chong HC; Ong SG; Mohamed Ismail A; Lee YYL; Gun SC
    Rheumatol Int; 2017 Oct; 37(10):1719-1725. PubMed ID: 28695274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.